Respiratory

A nationwide study presented at the CHEST Annual Meeting 2024 revealed rising trends in metabolically healthy obesity (MHO) among elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease

A strong link has been identified between the cumulative impact of neighborhood-level environmental and social factors, known as the “neighborhood exposome,” and the prevalence of asthma and COPD in U.S. adults

A new study has shown that the BACES score, a clinical tool used to predict mortality in non-tuberculous mycobacteria (NTM) lung disease, can also help predict treatment outcomes in patients with Mycobacterium avium complex lung disease (MAC-LD)

Pulmonary hypertension is a progressive and potentially fatal condition that can go undetected until it reaches advanced stages. A groundbreaking study presented at the CHEST Annual Meeting 2024 introduces a multimodal fusion model (MMF-PH) that incorporates AI

Findings from two Phase 3 clinical trials, BOREAS and NOTUS, revealed that dupilumab, a monoclonal antibody targeting key drivers of type 2 inflammation, improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD)

A new study presented at the CHEST Annual Meeting 2024 highlights the growing disparity in mortality rates for women with chronic obstructive pulmonary disease (COPD), especially those in rural areas.

Hospital stays lead to worsening fatigue and shortness of breath in patients with idiopathic pulmonary fibrosis (IPF) according to a new study presented at the CHEST 2024 Annual Meeting.

A digital health program, mPATH-Lung, has been shown to significantly improves lung cancer screening (LCS) rates among high-risk individuals.